NO20030507D0 - Tartratsalter av tiazolidindionderivater - Google Patents

Tartratsalter av tiazolidindionderivater

Info

Publication number
NO20030507D0
NO20030507D0 NO20030507A NO20030507A NO20030507D0 NO 20030507 D0 NO20030507 D0 NO 20030507D0 NO 20030507 A NO20030507 A NO 20030507A NO 20030507 A NO20030507 A NO 20030507A NO 20030507 D0 NO20030507 D0 NO 20030507D0
Authority
NO
Norway
Prior art keywords
tartrate salts
thiazolidinedione derivatives
thiazolidinedione
derivatives
tartrate
Prior art date
Application number
NO20030507A
Other languages
English (en)
Other versions
NO324595B1 (no
NO20030507L (no
Inventor
Bernadette Marie Choudary
Andrew Simon Craig
Tim Chien Ting Ho
Donald Colin Mackenzie
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20030507D0 publication Critical patent/NO20030507D0/no
Publication of NO20030507L publication Critical patent/NO20030507L/no
Publication of NO324595B1 publication Critical patent/NO324595B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
NO20030507A 2000-08-04 2003-01-31 Tartratsalt av tiazolidindionderivat, fremgangsmate for fremstilling derav, anvendelse derav og farmasoytisk preparat omfattende saltet NO324595B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019228.6A GB0019228D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003515 WO2002012234A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (3)

Publication Number Publication Date
NO20030507D0 true NO20030507D0 (no) 2003-01-31
NO20030507L NO20030507L (no) 2003-03-26
NO324595B1 NO324595B1 (no) 2007-11-26

Family

ID=9897030

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030507A NO324595B1 (no) 2000-08-04 2003-01-31 Tartratsalt av tiazolidindionderivat, fremgangsmate for fremstilling derav, anvendelse derav og farmasoytisk preparat omfattende saltet

Country Status (36)

Country Link
US (1) US20040048899A1 (no)
EP (1) EP1305312B1 (no)
JP (1) JP2004505972A (no)
KR (1) KR100755173B1 (no)
CN (1) CN1458931A (no)
AP (1) AP1814A (no)
AT (1) ATE393153T1 (no)
AU (1) AU2001276509A1 (no)
BG (1) BG107606A (no)
BR (1) BR0112981A (no)
CA (1) CA2417829A1 (no)
CZ (1) CZ2003316A3 (no)
DE (1) DE60133746T2 (no)
DK (1) DK1305312T3 (no)
DZ (1) DZ3467A1 (no)
EA (1) EA004764B1 (no)
EC (1) ECSP034469A (no)
ES (1) ES2302506T3 (no)
GB (1) GB0019228D0 (no)
HK (1) HK1057359A1 (no)
HR (1) HRP20030070A2 (no)
HU (1) HUP0300777A3 (no)
IL (2) IL154278A0 (no)
MA (1) MA25898A1 (no)
MX (1) MXPA03001087A (no)
NO (1) NO324595B1 (no)
NZ (1) NZ524032A (no)
OA (1) OA12352A (no)
PL (1) PL360703A1 (no)
PT (1) PT1305312E (no)
SI (1) SI1305312T1 (no)
SK (1) SK1442003A3 (no)
UA (1) UA76721C2 (no)
WO (1) WO2002012234A1 (no)
YU (1) YU16303A (no)
ZA (1) ZA200300963B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
AR047530A1 (es) 2004-02-04 2006-01-25 Novartis Ag Formas de sal de 4-(4-metilpiperazin-1-ilmetil)-n-(4-metil-3-(4-piridin-3-il)pirimidin-2-ilamino)fenil)-benzamida
JP2008505075A (ja) * 2004-06-30 2008-02-21 イーライ リリー アンド カンパニー １−（インドール−６−カルボニル−ｄ−フェニルグリシニル）−４−（１−メチルピペリジン−４−イル）ピペラジンｄ−酒石酸塩
US7435741B2 (en) * 2006-05-09 2008-10-14 Teva Pharmaceutical Industries, Ltd. 2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butanedioic acid, methods of preparation and compositions with rosiglitazone maleate
GB0616574D0 (en) * 2006-08-21 2006-09-27 Glaxo Group Ltd Compounds
DE102009053562A1 (de) 2009-11-18 2011-05-19 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Rosiglitazonsuccinat enthaltende pharmazeutische Zusammensetzung
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
US6288095B1 (en) * 1987-09-04 2001-09-11 Beecham Group P.L.C. Compounds
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5741803A (en) * 1992-09-05 1998-04-21 Smithkline Beecham Plc Substituted thiazolidinedionle derivatives

Also Published As

Publication number Publication date
BG107606A (bg) 2003-09-30
NO324595B1 (no) 2007-11-26
SK1442003A3 (en) 2004-05-04
OA12352A (en) 2006-05-16
DK1305312T3 (da) 2008-07-28
EP1305312B1 (en) 2008-04-23
IL154278A (en) 2009-02-11
ATE393153T1 (de) 2008-05-15
PT1305312E (pt) 2008-06-19
YU16303A (sh) 2006-01-16
DE60133746D1 (de) 2008-06-05
MXPA03001087A (es) 2003-05-27
IL154278A0 (en) 2003-09-17
DE60133746T2 (de) 2009-05-14
PL360703A1 (en) 2004-09-20
AU2001276509A1 (en) 2002-02-18
GB0019228D0 (en) 2000-09-27
KR20030022357A (ko) 2003-03-15
EP1305312A1 (en) 2003-05-02
NO20030507L (no) 2003-03-26
NZ524032A (en) 2004-07-30
HRP20030070A2 (en) 2005-02-28
BR0112981A (pt) 2003-08-26
MA25898A1 (fr) 2003-10-01
KR100755173B1 (ko) 2007-09-03
CA2417829A1 (en) 2002-02-14
WO2002012234A1 (en) 2002-02-14
DZ3467A1 (fr) 2002-02-14
AP2003002738A0 (en) 2003-03-31
HK1057359A1 (en) 2004-04-02
CZ2003316A3 (en) 2004-03-17
ECSP034469A (es) 2003-06-25
CN1458931A (zh) 2003-11-26
HUP0300777A3 (en) 2005-04-28
AP1814A (en) 2008-01-04
ZA200300963B (en) 2004-04-19
UA76721C2 (uk) 2006-09-15
EA200300234A1 (ru) 2003-06-26
SI1305312T1 (sl) 2008-08-31
US20040048899A1 (en) 2004-03-11
ES2302506T3 (es) 2008-07-16
HUP0300777A2 (hu) 2003-11-28
JP2004505972A (ja) 2004-02-26
EA004764B1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
NO20030134L (no) Fremstilling av olefinderivater
DK1448198T3 (da) Nicotin- eller isonicotin-benzothiazolderivater
ATE391505T1 (de) Benzothiazole derivative
NO20030507L (no) Tartratsalter av tiazolidindionderivater
NO20030530D0 (no) Tartratsalter av tiazolidindionderivater
NO20030508L (no) Tartratsalter av tiazolidindionderivater
NO20030531D0 (no) Tartratsalter av tiazolidindionderivater
EE200100381A (et) Morfolinobensamiidi uued soolad
SI1305310T1 (sl) Tartratne soli derivata tiazolidindiona
NO20025385L (no) Fremgangsmate for fremstilling av sulfonylbenzoylguanidiniumsalter

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees